Services

abc biopply offers a comprehensive portfolio of validated service packages based on the proprietary 3D CoSeedis in chip communication technology™. Utilizing 3D CoSeedis humanized multi-organoid models™, as well as traditional monolayer models, we specialize in assay endpoints useful for drug discovery and pharmaceutical development.

Our service packages address compound efficacy as well as the evaluation of toxicological liabilities. Taking advantage of the numerous benefits of abc biopply’s technology, we are able to make most accurate dosage, long term efficacy, and off-target toxicology predictions and thereby eliminate animal based alternative models to a large extend and increase successful clinical testing substantially. Moreover, our services deliver statistically highly reliable results in a very short time period.